Status:

COMPLETED

Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer

Lead Sponsor:

University of Connecticut

Collaborating Sponsors:

Hartford HealthCare

Seafood Industry Research Fund

Conditions:

Fatigue

Depression

Eligibility:

FEMALE

35-70 years

Phase:

NA

Brief Summary

Inflammation has been consistently associated with psychoneurological symptoms (PNS) among breast cancer survivors (BCS). Evidence supporting interventional strategies promoting symptom-self managemen...

Eligibility Criteria

Inclusion

  • diagnosed with BCA between 1 and 2 years prior to study enrollment
  • completed chemotherapy (except tamoxifen/aromatase inhibitors) and/or radiation
  • no evidence of cancer recurrence;
  • no chronic medical conditions involving the immune system or regular use of immunosuppressive medications;
  • no history of previous chemotherapy or cancer
  • no diagnosis of dementia or active psychosis;
  • 30-75 years of age
  • Able/willing to sign informed consent.

Exclusion

  • Women not meeting the inclusion criteria above;
  • Non English-speaking

Key Trial Info

Start Date :

April 11 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2020

Estimated Enrollment :

98 Patients enrolled

Trial Details

Trial ID

NCT04293874

Start Date

April 11 2018

End Date

November 1 2020

Last Update

September 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hartford HealthCare Cancer Institue

Hartford, Connecticut, United States, 06102